NBIAready: Online Collection of Natural History Patient-reported Outcome Measures
NCT02587858 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2020-10-08
Summary
The purpose of this study is to learn more about Neurodegeneration with Brain Iron Accumulation (NBIA) Disorders. Data is being collected on three types of NBIA disorders:
Pantothenate Kinase-Associated Neurodegeneration (PKAN), PLA2G6-associated Neurodegeneration (PLAN) and Beta-propeller Protein-associated Neurodegeneration (BPAN). The study will (1) collect information about how symptoms and findings in NBIA change over time and (2) identify measures of NBIA that can be used in future clinical trials. Participants will follow links to a secure website every 6 months for a period of 5-10 years to electronically complete a set of rating scales as related to their NBIA disorder.
Conditions
- Neurodegeneration With Brain Iron Accumulation (NBIA)
Sponsors & Collaborators
-
Oregon Health and Science University
collaborator OTHER -
Susan J. Hayflick
lead OTHER
Principal Investigators
-
Susan J Hayflick, MD · Oregon Health and Science University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2025-04-30
- Completion
- 2025-04-30
Countries
- United States
Study Locations
More Related Trials
-
Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS
NCT07156214 ·Status: RECRUITING ·Phase: NA
-
Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers
NCT05028764 ·Status: COMPLETED
-
SNAP: Study Nutrients in Adult PKU
NCT03858101 ·Status: COMPLETED
-
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
NCT00975689 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pyruvate Kinase Deficiency Natural History Study
NCT02053480 ·Status: COMPLETED
-
Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency Patients
NCT04098211 ·Status: ACTIVE_NOT_RECRUITING
-
Krabbe Disease Global Patient Registry
NCT02993796 ·Status: RECRUITING
-
Purine Supplementation in Patients With AICA-Ribosiduria
NCT06845501 ·Status: RECRUITING ·Phase: NA
-
Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)
NCT01705626 ·Status: COMPLETED
-
Taurine Therapy for SSADH Deficiency
NCT01608178 ·Status: COMPLETED
-
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
NCT07220265 ·Status: RECRUITING ·Phase: NA
-
Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
NCT04404530 ·Status: RECRUITING
-
A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype
NCT01358370 ·Status: COMPLETED
-
Giant Axonal Neuropathy Natural History Study
NCT01503125 ·Status: TERMINATED
-
Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU
NCT05356377 ·Status: COMPLETED
-
Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease
NCT06065605 ·Status: UNKNOWN
-
Natural History Study of Patients With MPS IIIA
NCT02746341 ·Status: COMPLETED
-
Natural History Study in Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia
NCT05020743 ·Status: TERMINATED
-
A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C
NCT05163288 ·Status: RECRUITING ·Phase: PHASE3
-
The Natural History Study of Patients With Sanfilippo Disease(s) (MPS3)
NCT05705674 ·Status: RECRUITING
-
Biological Variation of Phenylalanine in Patients With Hyperphenylalaninemia
NCT01869972 ·Status: COMPLETED
-
The Natural History of Infantile Globoid Cell Leukodystrophy
NCT00983879 ·Status: COMPLETED
-
FA Clinical Outcome Measures
NCT03090789 ·Status: ACTIVE_NOT_RECRUITING
-
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
NCT02124083 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenoprotein N-related Myopathy (SEPN1-RM)
NCT02505087 ·Status: TERMINATED ·Phase: PHASE2/PHASE3